Analysis of DNA gyrase supercoiling and of norfloxacin uptake in Escherichia coli GN14176, a moderately norfloxacin-resistant clinical isolate, indicated that resistance was associated with both an altered drug target and a reduction in drug uptake.
against strain GN14176 was 8 times higher than that against MH-5 and 128 times higher than that against KL-16. The IC50 for DNA gyrase from GN14176 was 100-fold higher than that for DNA gyrase from KL-16. This study also suggests that DNA gyrase is a target of norfloxacin in E. coli GN14176. However, the IC50 for GN14176 was the same as that for MH-5. That is, the inhibitory effects of norfloxacin on the supercoiling activity of DNA gyrase from GN14176 and MH-5 strains were not in parallel with the antibacterial activities against these strains. The results suggest that other factors also contribute to norfloxacin resistance in GN14176.
The uptake of norfloxacin by GN14176 was about onethird of that by KL-16 cells (Fig. 1) . We found previously that quinolone compounds penetrate the outer membrane of E. coli K-12 through the OmpF porin (6, 7). The electrophoretic pattern demonstrated that the amount of OmpF protein in the cell envelope was decreased in GN14176 (Fig. 2) . These results indicate that norfloxacin resistance in GN14176 was associated with alterations of the DNA gyrase and that decreased norfloxacin uptake was caused by the change of outer membrane proteins. The double-resistance mechanism of GN14176 could thus explain the resistance to norfloxacin that was eight times higher than that of MH-5, which appears to have a mutation only in DNA gyrase. We previously reported that the DNA gyrase of a clinical isolate of E. coli GN14181 highly resistant to norfloxacin (MIC, 100 ,ug/ml) is more resistant to norfloxacin (IC50, >800 p.g/ml) than the DNA gyrase of MH-5 (11) .
In laboratory strains, norfloxacin-resistant mutants with the alteration in both DNA gyrase and the cell membrane have not been obtained in a single step (7, 8) . However, highly norfloxacin-resistant clinical isolates have been isolated more frequently than expected (9) . GN14176 showed the low-level resistance to chloramphenicol and cefoxitin (data not shown) that is also seen in nfxB, norB, and norC mutants. This low-level multiple-antibiotic resistance with the alteration of outer membrane proteins has also been studied in clinical isolates of Serratia marcescens (10 
